Your browser doesn't support javascript.
loading
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Landi, Doriana; Cola, Gaia; Mantero, Vittorio; Balgera, Roberto; Moiola, Lucia; Nozzolillo, Agostino; Dattola, Vincenzo; Sinisi, Leonardo; Fantozzi, Roberta; Di Lemme, Sonia; Centonze, Diego; Mataluni, Giorgia; Nicoletti, Carolina Gabri; Marfia, Girolama Alessandra.
Afiliação
  • Landi D; University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy.
  • Cola G; University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy.
  • Mantero V; ASST Lecco, MS Center, Lecco, Italy.
  • Balgera R; ASST Lecco, MS Center, Lecco, Italy.
  • Moiola L; San Raffaele Hospital IRCCS, Multiple sclerosis center-Neurology Department, Milano, Italy.
  • Nozzolillo A; San Raffaele Hospital IRCCS, Multiple sclerosis center-Neurology Department, Milano, Italy.
  • Dattola V; Grande Ospedale Metropolitano Bianchi Melacrino Morelli, UOC Neurologia, Reggio Calabria, Italy.
  • Sinisi L; San Paolo Hospital ASL Napoli 1 Centro, Neurology Unit and MS Center, Napoli, Italy.
  • Fantozzi R; IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy.
  • Di Lemme S; IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy.
  • Centonze D; IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy; University of Rome Tor Vergata, Department of Systems Medicine, Roma, Italy.
  • Mataluni G; University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy.
  • Nicoletti CG; University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy.
  • Marfia GA; University of Rome Tor Vergata, Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Roma, Italy; IRCCS Neuromed, Unit of Neurology, Pozzilli (IS), Italy.
Mult Scler Relat Disord ; 57: 103345, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35158454

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / COVID-19 / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / COVID-19 / Esclerose Múltipla Idioma: En Ano de publicação: 2022 Tipo de documento: Article